CD4 T Cell Decline Is Not Associated With Amino Acid Changes in HIV-1 gp120

Similar documents
Low ds/dn Does Not Correlate With High Variation of Amino Acid Sequences Along the gp120 Protein Structure

Nonsynonymous Amino Acid Mutations in gp120 Binding Sites are Related to Progression of HIV-1

Loyola Marymount University Department of Biology October 25, Zach, Matt, Mia, Will

Does A Significant Change in CD4 Cell Count Affect The Number of Amino Acid Mutations In A Subject s Corresponding DNA Sequence

ds/dn Ratios Do Not Provide A More Consistent Means of Comparison Between HIV-1 Progressor Groups

Correlation analysis between CD4 T Cell counts and genetic diversity indicate no relationship Mia Huddleston and Anindita Varshneya

Identification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist

Subtyping Sequences from Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline by Markham et al.

Multiple sequence alignment

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za

Analysis of protein modeling for envelope glycoprotein GP120 for HIV via bioinformatics approaches

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN GP160 PROTEIN OF HIV TYPE-1

Lecture 11. Immunology and disease: parasite antigenic diversity

Immunodeficiency. (2 of 2)

From Antibody to Vaccine a Tale of Structural Biology and Epitope Scaffolds

YUMI YAMAGUCHI-KABATA AND TAKASHI GOJOBORI* Center for Information Biology, National Institute of Genetics, Mishima , Japan

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)

HIV Anti-HIV Neutralizing Antibodies

DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester

Viral reproductive cycle

Week 5 Assignment: Annotated Bibliography

Boosts Following Priming with gp120 DNA

Human Immunodeficiency Virus

HIV life cycle revisited: What s new in basic science? Theresa Rossouw

numbe r Done by Corrected by Doctor

Human Immunodeficiency Virus type 1 (HIV-1) gp120 / Glycoprotein 120 ELISA Pair Set

Supporting Information

Week 5 Section. Junaid Malek, M.D.

number Done by Corrected by Doctor Ashraf Khasawneh

HIV INFECTION: An Overview

MedChem 401~ Retroviridae. Retroviridae

A Path to an HIV Vaccine: GSID Consortium Activities. Faruk Sinangil, PhD 4th Annual CAVD Meeting Miami, FL December 1-4, 2009

NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections

Attachment and Entry. Lecture 5 Biology W3310/4310 Virology Spring Who hath deceived thee so o-en as thyself? --BENJAMIN FRANKLIN

Exploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein

Dr. Ahmed K. Ali Attachment and entry of viruses into cells

Overview of the Joint HVTN/HPTN Research Portfolio. Theresa Gamble, PhD HPTN LOC May 15, 2018

HUMAN IMMUNODEFICIENCY VIRUS

How HIV Causes Disease Prof. Bruce D. Walker

Section 6. Junaid Malek, M.D.

Crystal structure of the neutralizing antibody HK20 in complex with its gp41 antigen

Carbohydrate-based strategies of antiviral therapeutics

Increased Functional Stability and Homogeneity of Viral Envelope Spikes through Directed Evolution

HIV: RECEPTORS AND CO-RECEPTORS

HS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations.

Lecture 6. Burr BIO 4353/6345 HIV/AIDS. Tetramer staining of T cells (CTL s) Andrew McMichael seminar: Background

Prevention of infection 2 : immunisation. How infection influences the host : viruses. Peter

Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS

5 Cell recognition and the immune system Exam-style questions. AQA Biology. 1 Figure 1 shows a phagocyte attracted to a bacterium.

Mutations in simian immunodeficiency virus protease cleavage sites 2 and12 impair in vitro virus production

19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics

Viruses defined acellular organisms genomes nucleic acid replicate inside host cells host metabolic machinery ribosomes

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

A PROJECT ON HIV INTRODUCED BY. Abdul Wahab Ali Gabeen Mahmoud Kamal Singer

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

Citation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside

The Rational Design of an AIDS Vaccine

Allergy and Immunology Review Corner: Chapter 13 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

HIV & AIDS: Overview

One of the classifications was if the virus is enveloped or naked.

Recombinant Baculovirus Derived HIV-1 Virus-Like Particles Elicit Potent Neutralizing Antibody Responses

Challenges in Designing HIV Env Immunogens for Developing a Vaccine

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Chapter13 Characterizing and Classifying Viruses, Viroids, and Prions

Chapter 08 Lecture Outline

Viral Genetics. BIT 220 Chapter 16

Investigation of the genetic differences between bovine herpesvirus type 1 variants and vaccine strains

, virus identified as the causative agent and ELISA test produced which showed the extent of the epidemic

5/6/17. Diseases. Disease. Pathogens. Domain Bacteria Characteristics. Bacteria Viruses (including HIV) Pathogens are disease-causing organisms

Research Online. Edith Cowan University. Constantinos K. Wibmer. Jinal N. Bhiman. Elin S. Gray Edith Cowan University,

Bioinformation Volume 5

Isolation of a Broadly Neutralizing Antibody with Low Somatic Mutation from a Chronically Infected HIV-1 Patient

Antiviral Chemotherapy

Last time we talked about the few steps in viral replication cycle and the un-coating stage:

Patricia Fitzgerald-Bocarsly

Cellular Immunity in Aging and HIV: Correlates of Protection. Immune Senescence

3. on T helper {cells / lymphocytes} ; 3. ACCEPT macrophages / dendritic cells / CD4 cells

Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood

08/02/59. Tumor Immunotherapy. Development of Tumor Vaccines. Types of Tumor Vaccines. Immunotherapy w/ Cytokine Gene-Transfected Tumor Cells

HIV-1 envelope glycoproteins isolated from Viremic non-progressors HIV-infected individuals are fully functional and cytophatic

Under the Radar Screen: How Bugs Trick Our Immune Defenses

There are approximately 30,000 proteasomes in a typical human cell Each proteasome is approximately 700 kda in size The proteasome is made up of 3


Picornaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Fig. 1: Schematic diagram of basic structure of HIV

Proteins and symmetry

MECHANISMS OF VIRAL MEMBRANE FUSION AND ITS INHIBITION

Tools to therapeutically harness the human antibody response

RAISON D ETRE OF THE IMMUNE SYSTEM:

Emerging Viruses. Part IIb Follow Up from Part I Vaccines and Inhibitors

Animal Models to Understand Immunity

Translation. Host Cell Shutoff 1) Initiation of eukaryotic translation involves many initiation factors

Severe Acute Respiratory Syndrome (SARS) Coronavirus

Protein Modeling Event

Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa

Intrinsic cellular defenses against virus infection

Structure of HIV. Virion contains a membrane envelope with a single viral protein= Env protein. Capsid made up of Gag protein

Transcription:

CD4 T Cell Decline Is Not Associated With Amino Acid Changes in HIV-1 gp120 Colin Wikholm and Isai Lopez BIOL 368: Bioinformatics Laboratory Department of Biology Loyola Marymount University November 15, 2016

Outline HIV-1 gp120 structure affects infection of host cells, and evasion of host immunity, and virus survival. Markham et al. (1998) found that high gp120 genetic diversity was associated with rapid CD4 T cell decline. We analyzed gp120 mutational changes to look for associations between amino acid diversity and rate of CD4 T cell decline. We found no significant difference in amino acid diversity between HIV-1 progressor groups. Future studies should narrow structural and functional analysis to the V3 region of gp120.

Outline HIV-1 gp120 structure affects infection of host cells, and evasion of host immunity, and virus survival. Markham et al. (1998) found that high gp120 genetic diversity was associated with rapid CD4 T cell decline. We analyzed gp120 mutational changes to look for associations between amino acid diversity and rate of CD4 T cell decline. We found no significant difference in amino acid diversity between HIV-1 progressor groups. Future studies should narrow structural and functional analysis to the V3 region of gp120.

http://alevelnotes.com/content_images/image85.gif Protein Primary Structure Determines Protein Folding and Protein Function Nonsynonymous mutations change the the amino acid sequence. Side chains alterations cause changes in protein folding, intermolecular interactions, and structure.

HIV-1 Expresses a Series of Surface Proteins for Infection of Host Cells The gp160 is cleaved into gp120 and gp41, which together form the viral spike.

HIV-1 Infection of Host Cell Involves Primary Binding, Secondary Binding, and Membrane Fusion 1. The gp120 binds to CD4, inducing conformational change in gp120. 2. The gp120 binding sites are exposed and CXCR4 binds to gp120. 3. The gp41 glycoprotein initiates fusion of virus and cell membranes. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3405824/

HIV-1 Infection of Host Cell Involves Primary Binding, Secondary Binding, and Membrane Fusion The gp120 amino acid sequence affects: a) Binding to CD4 b) Subsequent Chemokine receptor binding c) Neutralization by CD4 induced neutralizing antibodies https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3405824/

Outline HIV-1 gp120 structure affects infection of host cells and evasion of host immunity, and virus survival. Markham et al. (1998) found that high gp120 genetic diversity was associated with rapid CD4 T cell decline. We analyzed gp120 mutational changes to look for associations between amino acid diversity and rate of CD4 T cell decline. We found no significant difference in amino acid diversity between HIV-1 progressor groups. Future studies should narrow structural and functional analysis to the V3 region of gp120.

Markham et al. (1998) Found Higher gp120 Diversity in Patients With Rapid CD4 T Cell Decline Would there be higher gp120 amino acid diversity in patients with rapid CD4 T cell decline? We predicted that patients with higher CD4 T cell decline would have higher amino acid diversity at end of the study.

Outline HIV-1 gp120 structure affects infection of host cells and evasion of host immunity, and virus survival. Markham et al. (1998) found that high gp120 genetic diversity was associated with rapid CD4 T cell decline. We analyzed gp120 mutational changes to look for associations between amino acid diversity and rate of CD4 T cell decline. We found no significant difference in amino acid diversity between HIV-1 progressor groups. Future studies should narrow structural and functional analysis to the V3 region of gp120.

We Studied Amino Acid Diversity of Two Clones From Each Subject Diversity was calculated in clones within first and last visits, and compared between first and last visits. Diversity and change in diversity was compared for strong, weak, and no consensus amino acid positions. Total number of non-fully-conserved regions were also analyzed. Visualization of the gp120 protein structure was used to supplement statistical analysis.

Differences in Amino Acid Diversity and Change in Amino Acid Diversity Were Not Significant Visit and progressor type was not significantly associated with types of mutation regions. Progressor type still indicates possible relationship. P-Values of Two-Way Anova Tests Strong Weak Non- Consensus All Non-Fully- Conserved First vs. Last Visit Progressor Type Combined Interactions.284.574.413.266.074.267.187.094.692.109.633.981

Differences in Amino Acid Diversity and Change in Amino Acid Diversity Were Not Significant First Visit Last Visit Box plot confirms diversity trend depending on progressor type. Inter-visit mutational diversity shows little dependence on visit.

Sequence Alignment Shows Uneven Distribution of Mutational Regions Identical Different Similar Completely conserved V3 Region The V3 region shows overall low levels of conservation, but one central conserved region

Sequence Alignment Shows Uneven Distribution of Mutational Regions V3 Region Identical Different Similar Completely conserved

Sequence Alignment and Structure Analysis Confirm Variable Mutation Distribution Within the V3 Region Previous studies show the most variability in the dual β-sheets of the V3 region (Zolla-Pazner & Cardozo 2010) Identical Different Similar Completely conserved V3 Region

Outline HIV-1 gp120 structure affects infection of host cells and evasion of host immunity, and virus survival. Markham et al. (1998) found that high gp120 genetic diversity was associated with rapid CD4 T cell decline. We analyzed gp120 mutational changes to look for associations between amino acid diversity and rate of CD4 T cell decline. We found no significant difference in amino acid diversity between HIV-1 progressor groups. Future studies should narrow structural and functional analysis to the V3 region of gp120.

Limitations of this Analysis Suggest Future Studies Should Focus on Larger Sample Sizes and the V3 region Subject 15 seems to be possible outlier in first and final visit Markham at al. (1998) noted subject 15 as having unusually high genetic diversity. The sample size for this investigation limited each subject to two clones per visit. Continued investigation should test each clone. This study tested the entire gp120 region sequenced by Markham at al. (1998). Structural analysis shows uneven mutation distribution. Future structural analysis of HIV-1 should focus on the amino acid sequence composing the dual β-strands of the V3 region.

Acknowledgments Dr. Kam D. Dahlquist LMU Department of Biology

References Zolla-Pazner, S., & Cardozo, T. (2010). STRUCTURE FUNCTION RELATIONSHIPS OF HIV-1 ENVELOPE SEQUENCE-VARIABLE REGIONS PROVIDE A PARADIGM FOR VACCINE DESIGN. Nature Reviews. Immunology, 10(7), 527 535. http://doi.org/10.1038/nri2801